{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:14:00Z","timestamp":1772752440123,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020754","name":"Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China","doi-asserted-by":"publisher","award":["2021Y9189"],"award-info":[{"award-number":["2021Y9189"]}],"id":[{"id":"10.13039\/100020754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073871"],"award-info":[{"award-number":["82073871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024J011042"],"award-info":[{"award-number":["2024J011042"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J02016"],"award-info":[{"award-number":["2023J02016"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2021QH2014"],"award-info":[{"award-number":["2021QH2014"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bcp.2025.117174","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:56:56Z","timestamp":1752767816000},"page":"117174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["DNA damage agents trigger iNKT cell-mediated elimination of AML cells through activation of NF-\u03baB\/HLA-DRB6\/CD1d pathway"],"prefix":"10.1016","volume":"241","author":[{"given":"Guihui","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiurong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingna","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengmian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-0648","authenticated-orcid":false,"given":"Lixian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0005","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41467-022-31489-9","article-title":"Poor outcome of pediatric patients with acute myeloid leukemia harboring high FLT3\/ITD allelic ratios","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2025.117174_b0010","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1097\/HS9.0000000000000572","article-title":"Treatment for relapsed\/refractory acute myeloid leukemia","volume":"5","author":"Thol","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.bcp.2025.117174_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-017-0543-7","article-title":"Precision therapy for acute myeloid leukemia","volume":"11","author":"Yang","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-022-01308-1","article-title":"First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed\/refractory acute myeloid leukemia","volume":"15","author":"Jin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.117174_b0025","first-page":"11","article-title":"HA-1H T-cell receptor gene transfer to redirect virus-specific T cells for treatment of hematological malignancies after allogeneic stem cell transplantation: a phase 1 clinical study","volume":"2020","author":"van Balen","year":"1804","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.bcp.2025.117174_b0030","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/cncr.33690","article-title":"A phase 1b\/2 study of azacitidine with PD-L1 antibody avelumab in relapsed\/refractory acute myeloid leukemia","volume":"127","author":"Saxena","year":"2021","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2025.117174_b0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/intimm\/7.7.1157","article-title":"Predominant expression of invariant V\u03b114+ TCR\u03b1 chain in NK1.1+ T cell populations","volume":"7","author":"Makino","year":"1995","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117174_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cmet.2020.05.017","article-title":"Distinct iNKT cell populations use IFN\u03b3 or ER stress-induced IL-10 to control adipose tissue homeostasis","volume":"32","author":"LaMarche","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117174_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1109347","article-title":"CD8+ T-cell immunity orchestrated by iNKT cells","volume":"13","author":"Qin","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000316","article-title":"Phase II study of \u03b1-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer","volume":"8","author":"Toyoda","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2025.117174_b0055","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1428156","article-title":"Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells","volume":"7","author":"Dockry","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2025.117174_b0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clim.2017.08.002","article-title":"Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8+ invariant natural killer T cells","volume":"183","author":"Ghnewa","year":"2017","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117174_b0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molcel.2009.09.032","article-title":"A nuclear poly (ADP-ribose)-dependent signalosome confers DNA damage-induced I\u03baB kinase activation","volume":"36","author":"Stilmann","year":"2009","journal-title":"Mol. Cell"},{"issue":"21","key":"10.1016\/j.bcp.2025.117174_b0070","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.2174\/0929867327666201111142307","article-title":"A critical transcription factor NF-\u03baB as a cancer therapeutic target and its inhibitors as cancer treatment options","volume":"28","author":"Suhail","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2025.117174_b0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3324\/haematol.2017.178384","article-title":"CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma","volume":"103","author":"Li","year":"2018","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bcp.2025.117174_b0080","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/cancers12071943","article-title":"Pre-treatment mutational and transcriptomic landscape of responding metastatic melanoma patients to anti-PD1 immunotherapy","volume":"12","author":"Amato","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12935-023-02872-3","article-title":"The role of LncRNAs in tumor immunotherapy","volume":"23","author":"Pan","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2025.117174_b0090","article-title":"Biological function of long non-coding RNA (LncRNA) Xist","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.117174_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104578","article-title":"HOX transcript antisense RNA: an oncogenic lncRNA in diverse malignancies","volume":"118","author":"Ghafouri-Fard","year":"2021","journal-title":"Exp. Mol. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117174_b0100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2025.117174_b0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ncrna.2024.03.010","article-title":"Long non-coding RNA LIP interacts with PARP-1 influencing the efficiency of base excision repair","volume":"9","author":"Zuo","year":"2024","journal-title":"Non-coding RNA Res."},{"issue":"20","key":"10.1016\/j.bcp.2025.117174_b0110","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.3390\/cancers13205174","article-title":"The current landscape of NKT cell immunotherapy and the hills ahead","volume":"13","author":"Nelson","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2025.117174_b0115","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3389\/fimmu.2019.01126","article-title":"\u03b1-GalCer and iNKT cell-based cancer immunotherapy: Realizing the therapeutic potentials","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117174_b0120","article-title":"A bispecific T cell engager recruits both type 1 NKT and V\u03b39V\u03b42-T cells for the treatment of CD1d-expressing hematological malignancies","volume":"4","author":"Lameris","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bcp.2025.117174_b0125","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3389\/fimmu.2019.01542","article-title":"Invariant NKT cells from donor lymphocyte infusions (DLI-iNKTs) promote ex vivo lysis of leukemic blasts in a CD1d-dependent manner","volume":"10","author":"Jahnke","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117174_b0130","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.4049\/jimmunol.1003748","article-title":"Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state","volume":"186","author":"de Lalla","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117174_b0135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00262-022-03268-4","article-title":"Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment","volume":"72","author":"Stavrou","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"10.1016\/j.bcp.2025.117174_b0140","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117174_b0145","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3724\/abbs.2021011","article-title":"PARP-1 inhibitors enhance the chemosensitivity of leukemia cells by attenuating NF-\u043aB pathway activity and DNA damage response induced by Idarubicin: PARP-1 inhibitors attenuate DNA damage response","volume":"54","author":"Ke","year":"2022","journal-title":"Acta Biochim. Biophy. Sin."},{"issue":"3","key":"10.1016\/j.bcp.2025.117174_b0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/1541-7786.MCR-18-0523","article-title":"NF-\u03baB and poly (ADP-ribose) polymerase 1 form a positive feedback loop that regulates DNA repair in acute myeloid leukemia cells","volume":"17","author":"Li","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41421-024-00767-9","article-title":"NF-\u03baB RelB suppresses the inflammatory gene expression programs of dendritic cells by competing with RelA for binding to target gene promoters","volume":"11","author":"Navarro","year":"2025","journal-title":"Cell Discovery"},{"issue":"74","key":"10.1016\/j.bcp.2025.117174_b0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn6563","article-title":"TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells","volume":"7","author":"Delfanti","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117174_b0175","article-title":"Long non-coding RNAs and nuclear factor-\u03baB crosstalk in cancer and other human diseases","volume":"1873","author":"Gupta","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2025.117174_b0180","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117174_b0185","doi-asserted-by":"crossref","first-page":"e1471","DOI":"10.1002\/wrna.1471","article-title":"Cytoplasmic functions of long noncoding RNAs","volume":"9","author":"Noh","year":"2018","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"11","key":"10.1016\/j.bcp.2025.117174_b0190","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/biomedicines9111619","article-title":"Repeated \u03b1-GalCer administration induces a type 2 cytokine-biased iNKT cell response and exacerbates atopic skin inflammation in V\u03b114Tg NC\/Nga mice","volume":"9","author":"Park","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2025.117174_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457771","article-title":"Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy","volume":"15","author":"Takami","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117174_b0200","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/ijc.22019","article-title":"Chemotherapy pretreatment sensitizes solid tumor\u2010derived cell lines to V\u03b124+ NKT cell\u2010mediated cytotoxicity","volume":"119","author":"Mattarollo","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.bcp.2025.117174_b0205","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/2326-6066.CIR-17-0229","article-title":"Natural killer T-cell immunotherapy in combination with chemotherapy-induced immunogenic cell death targets metastatic breast cancer","volume":"5","author":"Gebremeskel","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bcp.2025.117174_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01654","article-title":"Cytotoxic chemotherapy as an immune stimulus: a molecular perspective on turning up the immunological heat on cancer","volume":"10","author":"Opzoomer","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117174_b0215","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/ijc.28118","article-title":"The combination therapy of \u03b1\u2010galactosylceramide and 5\u2010fluorouracil showed antitumor effect synergistically against liver tumor in mice","volume":"133","author":"Aketa","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117174_b0220","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2019.01014","article-title":"Beyond cDC1: emerging roles of DC crosstalk in cancer immunity","volume":"10","author":"Noubade","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:27:00Z","timestamp":1772749620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"alternative-id":["S0006295225004393"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117174","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA damage agents trigger iNKT cell-mediated elimination of AML cells through activation of NF-\u03baB\/HLA-DRB6\/CD1d pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117174"}}